Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin M Segal

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|October 23, 2025
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approachJeffrey Atkinson, Amy Dokiburra, Hayley Groover, et al.
Neuroradiology|May 14, 2011
Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMSWei Tian, Tong Zhu, Jianhui Zhong, et al.
Journal of Computer Assisted Tomography|July 19, 2012
Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesionsTiffany J Braley, Young Hen Lee, Suyash Mohan, et al.
Brain, Behavior, and Immunity|January 23, 2016
CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitisTimothy W Phares, Krista D DiSano, Stephen A Stohlman, et al.
Journal of Neuroimmunology|April 23, 2013
Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: implications for how viral infections might trigger multiple sclerosis exacerbationsEmily K Rainey-Barger, Pennelope K Blakely, Amanda K Huber, et al.
The Journal of Clinical Investigation|September 19, 2018
CNS-resident classical DCs play a critical role in CNS autoimmune diseaseDavid A Giles, Patrick C Duncker, Nicole M Wilkinson, et al.
The Lancet. Neurology|August 16, 2008
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging studyBenjamin M Segal, Cris S Constantinescu, Aparna Raychaudhuri, et al.
Frontiers in Neuroscience|January 8, 2025
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipelineJoseph S Miller, Michael Rose, Jonathan Roell, et al.
The Lancet. Neurology|October 10, 2022
Ageing and multiple sclerosisJennifer S Graves, Kristen M Krysko, Le H Hua, et al.
Brain, Behavior, and Immunity|October 12, 2010
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous systemEmily K Rainey-Barger, Julie M Rumble, Stephen J Lalor, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|October 23, 2025
Targeting senescent microglia in progressive multiple sclerosis: a geroscience-informed approachJeffrey Atkinson, Amy Dokiburra, Hayley Groover, et al.
Neuroradiology|May 14, 2011
Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMSWei Tian, Tong Zhu, Jianhui Zhong, et al.
Journal of Computer Assisted Tomography|July 19, 2012
Differences in diffusion tensor imaging-derived metrics in the corpus callosum of patients with multiple sclerosis without and with gadolinium-enhancing cerebral lesionsTiffany J Braley, Young Hen Lee, Suyash Mohan, et al.
Brain, Behavior, and Immunity|January 23, 2016
CXCL13 promotes isotype-switched B cell accumulation to the central nervous system during viral encephalomyelitisTimothy W Phares, Krista D DiSano, Stephen A Stohlman, et al.
Journal of Neuroimmunology|April 23, 2013
Virus-induced CD8+ T cells accelerate the onset of experimental autoimmune encephalomyelitis: implications for how viral infections might trigger multiple sclerosis exacerbationsEmily K Rainey-Barger, Pennelope K Blakely, Amanda K Huber, et al.
The Journal of Clinical Investigation|September 19, 2018
CNS-resident classical DCs play a critical role in CNS autoimmune diseaseDavid A Giles, Patrick C Duncker, Nicole M Wilkinson, et al.
The Lancet. Neurology|August 16, 2008
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging studyBenjamin M Segal, Cris S Constantinescu, Aparna Raychaudhuri, et al.
Frontiers in Neuroscience|January 8, 2025
A mini review of leveraging biobanking in the identification of novel biomarkers in neurological disorders: insights from a rapid single-cell sequencing pipelineJoseph S Miller, Michael Rose, Jonathan Roell, et al.
The Lancet. Neurology|October 10, 2022
Ageing and multiple sclerosisJennifer S Graves, Kristen M Krysko, Le H Hua, et al.
Brain, Behavior, and Immunity|October 12, 2010
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous systemEmily K Rainey-Barger, Julie M Rumble, Stephen J Lalor, et al.
Pageof 10